These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7705765)

  • 1. Improving insulin therapy: achievements and challenges.
    Galloway JA; Chance RE
    Horm Metab Res; 1994 Dec; 26(12):591-8. PubMed ID: 7705765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues.
    Rolla AR; Rakel RE
    Clin Ther; 2005 Aug; 27(8):1113-25. PubMed ID: 16199240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin analogues in the management of diabetes.
    Vázquez-Carrera M; Silvestre JS
    Methods Find Exp Clin Pharmacol; 2004; 26(6):445-61. PubMed ID: 15349139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin formulations--a review.
    Gualandi-Signorini AM; Giorgi G
    Eur Rev Med Pharmacol Sci; 2001; 5(3):73-83. PubMed ID: 12004916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 1 diabetes mellitus: effective insulin strategies with less hypoglycemia.
    Bolli GB
    Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):13-20. PubMed ID: 19667675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic advantages of insulin analogues and premixed insulin analogues over human insulins: impact on efficacy and safety.
    Rolla A
    Am J Med; 2008 Jun; 121(6 Suppl):S9-S19. PubMed ID: 18514090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled human insulin: new drug. No short-term advantages, too many unknowns in the long term.
    Prescrire Int; 2006 Dec; 15(86):203-9. PubMed ID: 17165235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Update on new insulins].
    Philips JC; Radermecker R
    Rev Med Suisse; 2005 Aug; 1(30):1936-8, 1940-1. PubMed ID: 16200936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapies for diabetes management: an update for the practicing clinician.
    Meneghini L; Hirsch IB
    Semin Thorac Cardiovasc Surg; 2006; 18(4):379-89. PubMed ID: 17395035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in diabetes for the millennium: insulin treatment and glucose monitoring.
    Einhorn D
    MedGenMed; 2004 Sep; 6(3 Suppl):8. PubMed ID: 15647713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future therapy of diabetes mellitus.
    Takei I; Kasatani T
    Biomed Pharmacother; 2004 Dec; 58(10):578-81. PubMed ID: 15589066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premixed insulin treatment for type 2 diabetes: analogue or human?
    Garber AJ; Ligthelm R; Christiansen JS; Liebl A
    Diabetes Obes Metab; 2007 Sep; 9(5):630-9. PubMed ID: 17697056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive insulin therapy: Part I. Basic principles.
    Hirsch IB; Herter CD
    Am Fam Physician; 1992 May; 45(5):2141-7. PubMed ID: 1575109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New trends in therapy of diabetes. More freedom, fewer risks, comfortable insulin administration].
    Harsch IA; Hahn EG; Ficker JH
    MMW Fortschr Med; 2000 Jul; 142(28-29):24-6. PubMed ID: 10959155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovative insulins--where do analogues fit?
    Phillips LK; Phillips PJ
    Aust Fam Physician; 2006 Dec; 35(12):969-73. PubMed ID: 17149471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin glargine: long-acting basal insulin analog for improved metabolic control.
    Gerich JE
    Curr Med Res Opin; 2004 Jan; 20(1):31-7. PubMed ID: 14741069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.